Peripubertal aromatase inhibition in male rats has adverse long-term effects on bone strength and growth and induces prostatic hyperplasia

Journal of Endocrinology

Volumn 207, Issue 1, 2010, Pages 27-34

  Bajpai, Anurag ^a,b   Simm, Peter J ^a,b,c   McPherson, Stephen J ^d   Russo, Vincenzo C ^a,b,c   Azar, Walid J ^a,b,c   Wark, John D ^c   Risbridger, Gail P ^d   Werther, George A ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; LETROZOLE; SOMATOMEDIN C; AROMATASE INHIBITOR; LUTEINIZING HORMONE; NITRILE; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BONE GROWTH; BONE STRENGTH; CONTROLLED STUDY; ENZYME INHIBITION; GROWTH INHIBITION; MALE; METABOLIC PARAMETERS; NONHUMAN; PREPUBERTY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT; TESTIS SIZE; ANIMAL; BLOOD; BONE; BONE DENSITY; BONE DEVELOPMENT; CHILD; DRUG EFFECTS; GROWTH DISORDERS; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE; PROSTATIC HYPERPLASIA; SEXUAL MATURATION; TESTIS; WISTAR RAT;

ANIMALS; AROMATASE INHIBITORS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CHILD; GROWTH DISORDERS; HUMANS; LUTEINIZING HORMONE; MALE; NITRILES; PROSTATE; PROSTATIC HYPERPLASIA; RATS; RATS, WISTAR; SEXUAL MATURATION; TESTIS; TRIAZOLES;

EID: 77957121856     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0006     Document Type: Article

References (34)

1. Bilezikian JP, Morishima A, Bell J & Grumbach MM 1998 Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. New England Journal of Medicine 339 599-603. (doi:10.1056/NEJM199808273390905)
2. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS & Simpson ER 1997 Effect of testosterone and estradiol in a man with aromatase deficiency. New England Journal of Medicine 337 91-95. (doi:10.1056/NEJM199707103370204)
3. Dunkel L 2009 Update on the role of aromatase inhibitors in growth disorders. Hormone Research 71 (Supplement 1) 57-63. (doi:10.1159/000178040)
4. Eshet R, Maor G, Ben Ari T, Ben Eliezer M, Gat-Yablonski G & Phillip M 2004 The aromatase inhibitor letrozole increases epiphyseal growth plate height and tibial length in peripubertal male mice. Journal of Endocrinology 182 165-172. (doi:10.1677/joe.0.1820165) (Pubitemid 39076912)
5. Harkonen P & Makela S 2004 Role of estrogens in development of prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 92 297-305. (doi:10.1016/j.jsbmb.2004.10.016)
6. Hero M, Norjavaara E & Dunkel L 2005 Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism 90 6396-6402. (doi:10.1210/jc.2005-1392)
7. Hero M, Ankarberg-Lindgren C, Taskinen MR & Dunkel L 2006a Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition. European Journal of Endocrinology 155 453-460. (doi:10.1530/eje.1.02226)
8. Hero M, Wickman S & Dunkel L 2006b Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clinical Endocrinology 64 510-513. (doi:10.1111/j.1365-2265.2006.02499.x)
9. Hero M, Makitie O, Kroger H, Nousiainen E, Toiviainen-Salo S & Dunkel L 2009 Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature. Hormone Research 71 290-297. (doi:10.1159/000208803)
10. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S et al. 2000 Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. PNAS 97 12735-12740. (doi:10.1073/pnas.97.23.12735)
11. Kumru S, Yildiz AA, Yilmaz B, Sandal S & Gurates B 2007 Effects of aromatase inhibitors letrozole and anastrazole on bone metabolism and steroid hormone levels in intact female rats. Gynecological Endocrinology 23 556-561. (doi:10.1080/09513590701557119) (Pubitemid 47613729)
12. Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M & Stener-Victorin E 2007 A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovarian syndrome. Endocrinology 148 3781-3791. (doi:10.1210/en.2007-0168)
13. Mauras N, Welch S, Rini A & Klein KO 2004 An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys. Journal of Pediatric Endocrinology and Metabolism 17 1597-1606.
14. Mauras N, Bell J, Snow BG & Winslow KL 2005 Sperm analysis in growth hormone-deficient adolescents previously treated with an aromatase inhibitor: comparison with normal controls. Fertility and Sterility 84 239-242. (doi:10.1016/j.fertnstert.2005.02.012) (Pubitemid 40991490)
15. Mauras N, Gonzalez de Pijem L, Hsiang HY, Desrosiers P, Rapaport R, Schwartz ID, Klein KO, Singh RJ, Miyamoto A & Bishop K 2008 Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. Journal of Clinical Endocrinology and Metabolism 93 823-831. (doi:10.1210/jc.2007-1559)
16. McPherson SJ, Wang H, Jones ME, Pedersen J, Iismaa TP, Wreford N, Simpson ER & Risbridger GP 2001 Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 142 2458-2467. (doi:10.1210/en.142.6.2458)
17. McPherson SJ, Ellem SJ & Risbridger GP 2008 Estrogen-regulated development and differentiation of the prostate. Differentiation 76 660-670. (doi:10.1111/j.1432-0436.2008.00291.x)
18. Morishima A, Grumbach MM, Simpson ER, Fisher C & Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 80 3689-3698. (doi:10.1210/jc.80.12.3689)
19. Murata Y, Robertson KM, Jones ME & Simpson ER 2002 Effect of estrogen deficiency in the male: the ArKO mouse model. Molecular and Cellular Endocrinology 193 7-12. (doi:10.1016/S0303-7207(02)00090-4) (Pubitemid 34823602)
20. Nolan LA & Levy A 2006 The effects of testosterone and oestrogen on gonadectomised and intact male rat anterior pituitary mitotic and apoptotic activity. Journal of Endocrinology 188 387-396. (doi:10.1677/joe.1.06508)
21. O'Donnell L, McLachlan RI, Wreford NG & Robertson DM 1994 Testosterone promotes the conversion of round spermatids between stages VII and VIII of the rat spermatogenic cycle. Endocrinology 135 2608-2614. (doi:10.1210/en.135.6.2608)
22. Oz OK, Zerwekh JE, Fisher C, Graves K, Nanu L, Millsaps R & Simpson ER 2000 Bone has a sexually dimorphic response to aromatase deficiency. Journal of Bone and Mineral Research 15 507-514. (doi:10.1359/jbmr.2000.15.3.507) (Pubitemid 30134095)
23. Prins GS, Huang L, Birch L & Pu Y 2006 The role of estrogens in normal and abnormal development of the prostate gland. Annals of the New York Academy of Sciences 1089 1-13. (doi:10.1196/annals.1386.009) (Pubitemid 47092064)
24. Prins GS, Birch L, Tang WY & Ho SM 2007 Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reproductive Toxicology 23 374-382. (doi:10.1016/j.reprotox.2006.10.001) (Pubitemid 46602925)
25. Robertson KM, O'Donnell L, Jones ME, Meachem SJ, Boon WC, Fisher CR, Graves KH, McLachlan RI & Simpson ER 1999 Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. PNAS 96 7986-7991. (doi:10.1073/pnas.96.14.7986)
26. Shulman DI, Francis GL, Palmert MR & Eugster EA 2008 Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development. Pediatrics 121 e975-e983. (doi:10.1542/peds.2007-2081)
27. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB & Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine 331 1056-1061. (doi:10.1056/NEJM199410203311604)
28. Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, Onishi T, Sugiura T & Shizuta Y 2003 Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. Journal of Endocrinology 176 237-246. (doi:10.1677/joe.0.1760237) (Pubitemid 36284816)
29. Turner KJ, Morley M, Atanassova N, Swanston ID & Sharpe RM 2000 Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility. Journal of Endocrinology 164 225-238. (doi:10.1677/joe.0.1640225) (Pubitemid 30114670)
30. Vanderschueren D, van Herck E, Nijs J, Ederveen AG, De Coster R & Bouillon R 1997 Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 138 2301-2307. (doi:10.1210/en.138.6.2301) (Pubitemid 27215229)
31. Venken K, Schuit F, Van Lommel L, Tsukamoto K, Kopchick JJ, Coschigano K, Ohlsson C, Moverare S, Boonen S, Bouillon R et al. 2005 Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis. Journal of Bone and Mineral Research 20 2138-2149. (doi:10.1359/JBMR.050811)
32. Venken K, De Gendt K, Boonen S, Ophoff J, Bouillon R, Swinnen JV, Verhoeven G & Vanderschueren D 2006 Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. Journal of Bone and Mineral Research 21 576-585. (doi:10.1359/jbmr.060103)
33. Wickman S, Sipila I, Ankarberg-Lindgren C, Norjavaara E & Dunkel L 2001 A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet 357 1743-1748. (doi:10.1016/S0140-6736(00)04895-9) (Pubitemid 32524203)
34. Wickman S, Kajantie E & Dunkel L 2003 Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys. Journal of Clinical Endocrinology and Metabolism 88 3785-3793. (doi:10.1210/jc.2002-021643)